Key points from article :
Specialised viruses called bacteriophages are used to target cancer cells in the brains
of mice.
Cancer-targeting viruses don’t enter healthy cells and are safe for use in human tissues.
Viral therapy with low dose temozolomide leads to regression of tumours in mice with
glioblastoma.
Phage therapy with TMZ showed the greatest survival benefit compared to TMZ or
phage therapy alone.
Trials in cancer patients could begin within the next 3-5 years in the USA or in the UK.
Imperial College London running the clinical trial.
The study was published in journal EMBO Molecular Medicine.
